In nearly 90% of patients with human B-cell leukemia and lymphoma, as well as other significant tumors, high methylation of ER genes and low ER expression, along with noncoding RNA expression, chromatin remodeling, and posttranslational modifications, are observed 159-162. Here, ESR1 is linked to lymphoma.